Patients with low OCT-1 activity and high ABCB1 fold rise have poor long-term outcomes in response to tyrosine kinase inhibitor therapy

Laura Eadie; Timothy Hughes; Deborah White

doi:10.1038/s41375-018-0101-5

Patients with low OCT-1 activity and high ABCB1 fold rise have poor long-term outcomes in response to tyrosine kinase inhibitor therapy

Laura Eadie, Timothy Hughes, Deborah White

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2288-2291
Number of pages	4
Journal	Leukemia
Volume	32
Issue number	10
DOIs	https://doi.org/10.1038/s41375-018-0101-5
Publication status	Published or Issued - 1 Oct 2018

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1038/s41375-018-0101-5

Cite this

@article{ab958abda7094605a123f6c4f87d429d,

title = "Patients with low OCT-1 activity and high ABCB1 fold rise have poor long-term outcomes in response to tyrosine kinase inhibitor therapy",

author = "Laura Eadie and Timothy Hughes and Deborah White",

year = "2018",

month = oct,

day = "1",

doi = "10.1038/s41375-018-0101-5",

language = "English",

volume = "32",

pages = "2288--2291",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Patients with low OCT-1 activity and high ABCB1 fold rise have poor long-term outcomes in response to tyrosine kinase inhibitor therapy

AU - Eadie, Laura

AU - Hughes, Timothy

AU - White, Deborah

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85045287559&partnerID=8YFLogxK

U2 - 10.1038/s41375-018-0101-5

DO - 10.1038/s41375-018-0101-5

M3 - Article

C2 - 29654270

AN - SCOPUS:85045287559

VL - 32

SP - 2288

EP - 2291

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 10

ER -

Patients with low OCT-1 activity and high ABCB1 fold rise have poor long-term outcomes in response to tyrosine kinase inhibitor therapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this